wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q33956056-0902DAB1-4D7E-4DCB-A8F5-F037A7BEACC2
Q33956056-0902DAB1-4D7E-4DCB-A8F5-F037A7BEACC2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33956056-0902DAB1-4D7E-4DCB-A8F5-F037A7BEACC2
Anti-angiogenesis therapies: their potential in cancer management
P2860
Q33956056-0902DAB1-4D7E-4DCB-A8F5-F037A7BEACC2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33956056-0902DAB1-4D7E-4DCB-A8F5-F037A7BEACC2
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
0044b322801b53277110ffdb51a702d5026c8097
P2860
Phase II trial of single-agent bevacizumab followed by bevacizumab plus irinotecan at tumor progression in recurrent glioblastoma